Evidence map›Paper›PMID 37461693›Full record

ArticleResearch square2023

Prefrontal Cortex Astroglia Modulate Anhedonia-like Behavior.

S A Codeluppi, M Xu, Y Bansal, A E Lepack, V Duric, M Chow, J Muir, R C Bagot, P Licznerski, S L Wilber and 5 more

Open access · greenAbstract readPreprint
In one paragraph

Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

S A CodeluppiCampbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, Canada.
M XuDepartment of Psychiatry, Yale University, New Haven, USA.
Y BansalCampbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, Canada.
A E LepackDepartment of Psychiatry, Yale University, New Haven, USA.
V DuricDepartment of Psychiatry, Yale University, New Haven, USA.
M ChowCampbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, Canada.
J MuirIntegrated Program in Neuroscience, McGill University, Montréal, Canada.
R C BagotDepartment of Psychology, McGill University, Montreal, Canada.
P LicznerskiDepartment of Psychiatry, Yale University, New Haven, USA.
S L WilberDepartment of Psychiatry, Yale University, New Haven, USA.
G SanacoraDepartment of Psychiatry, Yale University, New Haven, USA.ORCID 0000-0003-3722-8829
E SibilleCampbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, Canada.ORCID 0000-0001-5832-6570
R S DumanDepartment of Psychiatry, Yale University, New Haven, USA.ORCID 0000-0001-8690-8439
C PittengerDepartment of Psychiatry, Yale University, New Haven, USA.ORCID 0000-0003-2117-9321
M BanasrCampbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, Canada.
Yale University · USCentre for Addiction and Mental Health · CAMcGill University · CA

Funding

Effects of Stress and Glutamatergic Agents on Glutamate Cycling and BehaviorR01MH081211 · NIMH · YALE UNIVERSITY · PI SANACORA, GERARD · 2009 to 2013
$1.8M
NIMH NIH HHS R01 MH081211
6 · The paper itself

Abstract

Reductions of astroglia expressing glial fibrillary acidic protein (GFAP) are consistently found in the prefrontal cortex (PFC) of patients with depression and in rodent chronic stress models. Here, we examine the consequences of PFC GFAP+ cell depletion and cell activity enhancement on depressive-like behaviors in rodents. Using viral expression of diphtheria toxin receptor in PFC GFAP+ cells, which allows experimental depletion of these cells following diphtheria toxin administration, we demonstrated that PFC GFAP+ cell depletion induced anhedonia-like behavior within 2 days and lasting up to 8 days, but no anxiety-like deficits. Conversely, activating PFC GFAP+ cell activity for 3 weeks using designer receptor exclusively activated by designer drugs (DREADDs) reversed chronic restraint stress-induced anhedonia-like deficits, but not anxiety-like deficits. Our results highlight a critical role of cortical astroglia in the development of anhedonia and further support the idea of targeting astroglia for the treatment of depression.

Identifiers

PMID37461693
PMCPMC10350119
OpenAlexW4382653437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.